Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Papi

Showing results (91-100 of 428) with videos related to

Pageof 43
Sort By:
International Journal of Chronic Obstructive Pulmonary Disease|December 10, 2015
The EFFECT trial: evaluating exacerbations, biomarkers, and safety outcomes with two dose levels of fluticasone propionate/formoterol in COPDAlberto Papi, Paul W Jones, Prashant S Dalvi, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 23, 2023
Burden of Uncontrolled Severe Asthma With and Without Elevated Type-2 Inflammatory BiomarkersBo Ding, Stephanie Chen, Eleni Rapsomaniki, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|April 23, 2016
Long-Term Fluticasone Propionate/Formoterol Fumarate Combination Therapy Is Associated with a Low Incidence of Severe Asthma ExacerbationsAlberto Papi, Adel H Mansur, Tetyana Pertseva, et al.
Respiratory Research|January 8, 2020
Risk factors for exacerbations and pneumonia in patients with chronic obstructive pulmonary disease: a pooled analysisBenjamin F Hartley, Neil C Barnes, Sally Lettis, et al.
European Journal of Internal Medicine|February 10, 2021
Inhaled long-acting muscarinic antagonists in asthma - A narrative reviewAlberto Papi, Leonardo M Fabbri, Huib A M Kerstjens, et al.
American Journal of Respiratory and Critical Care Medicine|October 14, 2025
The ROME COPD Exacerbation Proposal Works! Time to Move ForwardBartolome R Celli, Leonardo M Fabbri, Gerard J Criner, et al.
Therapeutic Advances in Respiratory Disease|September 30, 2021
Manifesto on the overuse of SABA in the management of asthma: new approaches and new strategiesGiorgio Walter Canonica, Pierluigi Paggiaro, Francesco Blasi, et al.
Respiratory Medicine|December 25, 2023
Can the Rome classification of chronic obstructive pulmonary disease exacerbation severity be applied in the hospital setting?Marianna Cometa, Antonio Ursitti, Lorenzo Pasquale Lombardo, et al.
Chest|June 17, 2006
Up-regulated membrane and nuclear leukotriene B4 receptors in COPDEmanuela Marian, Simonetta Baraldo, Annalisa Visentin, et al.
Journal of Asthma and Allergy|June 19, 2023
Symptom Burden, Health Status, and Productivity in Patients with Uncontrolled and Controlled Severe Asthma in NOVELTYBo Ding, Stephanie Chen, Divyansh Srivastava, et al.
Pageof 43

Showing results (91-100 of 428) with videos related to

Sort By:
Pageof 43
International Journal of Chronic Obstructive Pulmonary Disease|December 10, 2015
The EFFECT trial: evaluating exacerbations, biomarkers, and safety outcomes with two dose levels of fluticasone propionate/formoterol in COPDAlberto Papi, Paul W Jones, Prashant S Dalvi, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 23, 2023
Burden of Uncontrolled Severe Asthma With and Without Elevated Type-2 Inflammatory BiomarkersBo Ding, Stephanie Chen, Eleni Rapsomaniki, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|April 23, 2016
Long-Term Fluticasone Propionate/Formoterol Fumarate Combination Therapy Is Associated with a Low Incidence of Severe Asthma ExacerbationsAlberto Papi, Adel H Mansur, Tetyana Pertseva, et al.
Respiratory Research|January 8, 2020
Risk factors for exacerbations and pneumonia in patients with chronic obstructive pulmonary disease: a pooled analysisBenjamin F Hartley, Neil C Barnes, Sally Lettis, et al.
European Journal of Internal Medicine|February 10, 2021
Inhaled long-acting muscarinic antagonists in asthma - A narrative reviewAlberto Papi, Leonardo M Fabbri, Huib A M Kerstjens, et al.
American Journal of Respiratory and Critical Care Medicine|October 14, 2025
The ROME COPD Exacerbation Proposal Works! Time to Move ForwardBartolome R Celli, Leonardo M Fabbri, Gerard J Criner, et al.
Therapeutic Advances in Respiratory Disease|September 30, 2021
Manifesto on the overuse of SABA in the management of asthma: new approaches and new strategiesGiorgio Walter Canonica, Pierluigi Paggiaro, Francesco Blasi, et al.
Respiratory Medicine|December 25, 2023
Can the Rome classification of chronic obstructive pulmonary disease exacerbation severity be applied in the hospital setting?Marianna Cometa, Antonio Ursitti, Lorenzo Pasquale Lombardo, et al.
Chest|June 17, 2006
Up-regulated membrane and nuclear leukotriene B4 receptors in COPDEmanuela Marian, Simonetta Baraldo, Annalisa Visentin, et al.
Journal of Asthma and Allergy|June 19, 2023
Symptom Burden, Health Status, and Productivity in Patients with Uncontrolled and Controlled Severe Asthma in NOVELTYBo Ding, Stephanie Chen, Divyansh Srivastava, et al.
Pageof 43